The Netherlands: Bridgefield Capital agrees acquisition of Philips Emergency Care business
Royal Philips, a global leader in health technology, has agreed to sell its Emergency Care business, to Bridgefield Capital, a US-based investment firm.
Terms of...
France: Ipsen adds to late-stage oncology pipeline with acquisition of Kartos Therapeutics
In its second major deal announcement of the week following news of its proposed acquisition of Memo Therapeutics for in excess of €700m, France...
UK: Starpharma and Medicxi join forces to co-found Petalion
Australia based global biopharmaceutical company, Starpharma, has entered into a strategic partnership with Medicxi, a life sciences investment firm, to co-found a new UK-based...
Finland: Northern Horizon’s evergreen fund, ACSIF, acquires care home in Finland
Specialist Nordic social infrastructure asset manager Northern Horizon has expanded its healthcare portfolio with the acquisition of a care home under development in Espoo,...
UK: Atlas Health holds final close of debut Atlas Health Fund I at £400m...
Atlas Health, a private equity fund established to invest in European Healthcare companies, has held an oversubscribed final close of its debut fund, Atlas...
UK: Bicycle Therapeutics raises US$555m via PIPE
Nasdaq-listed Bicycle Therapeutics, a UK-headquartered pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, has...
UK: Ashish Sunkara takes up new role as director Healthcare Investment Banking at RBC
Ashish Sunkara has taken up a new position as director Healthcare Investment Banking at RBC Capital Markets.
Sunkara has been with RBC since 2022 as...
Hong Kong: Euroeyes sees bright future with Union Medical deal
German eye clinic group EuroEyes has inked an ophthalmology joint venture with Hong Kong’s Union Medical Group to look at expansion in China. They...
UK: Kvika closes new UK lower-middle market private equity fund
Kvika, the UK subsidiary of Iceland-based Kvika banki, has closed HCPII Fund, surpassing its target with backing from new and existing investors across Iceland...
UK: Schottelius succeeds McCafferty as CEO of Maxion Therapeutics
Maxion Therapeutics, a biotech company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, has appointed Dr Arndt Schottelius has its new CEO. The...
Advertisement
